Cargando…
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents
Multiple sclerosis (MS) is a neurodegenerative disease characterized by demyelination and inflammation. Dysregulated lipid metabolism and mitochondrial dysfunction are hypothesized to play a key role in MS. Carnitine Palmitoyl Transferase 1 (CPT1) is a rate-limiting enzyme for beta-oxidation of fatt...
Autores principales: | Mørkholt, Anne Skøttrup, Oklinski, Michal Krystian, Larsen, Agnete, Bockermann, Robert, Issazadeh-Navikas, Shohreh, Nieland, Jette Goller Kloth, Kwon, Tae-Hwan, Corthals, Angelique, Nielsen, Søren, Nieland, John Dirk Vestergaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286491/ https://www.ncbi.nlm.nih.gov/pubmed/32520953 http://dx.doi.org/10.1371/journal.pone.0234493 |
Ejemplares similares
-
Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolism
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2017) -
Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
por: Trabjerg, Michael Sloth, et al.
Publicado: (2020) -
Inhibition of carnitine palmitoyl-transferase 1 is a potential target in a mouse model of Parkinson’s disease
por: Trabjerg, Michael Sloth, et al.
Publicado: (2023) -
Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS
por: Trabjerg, Michael Sloth, et al.
Publicado: (2021) -
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
por: Mørkholt, Anne Skøttrup, et al.
Publicado: (2019)